06/19/2017
Curefunding
Fund Dr. Rettig's research Chip in to help Many vs Cancer raise $300,000 for Dr. Matthew Rettig's groundbreaking research into prostate cancer genes. Read More
06/02/2017
Precision medicine taken to the next level: figuring out why tumors have become drug-resistant
Precision medicine is an emerging strategy for treating cancer, in which the unique mutations that occur in an individual’s tumor are used to select therapies that the tumor will likely be susceptible to. For a new treatment called PARP-inhibitors, this strategy of identifying patients who will benefit has been highly. Read More
“Get checked under the hood. Be a responsible grown-up.”
So, you’re 42. You’re into health and fitness, and fairly attuned to your body: you know something’s not right with your urinary tract, and you go to the doctor to get it checked out. Prostate cancer’s not on your radar. Why should it be? You’re young, you’re healthy, you have. Read More
2017 Prostate Cancer Survey
At PCF, we proudly work every day to advance world-class research in an effort to prevent and, eventually, eradicate prostate cancer. We firmly believe that fostering an open and inclusive community is the fastest way to move our research forward. That is why I am so proud to announce our. Read More
05/11/2017
Will Your Cancer Respond to Hormone Therapy?
Hormone therapy is a standard treatment for metastatic prostate cancer patients but may also benefit a subset of localized prostate cancer patients who underwent surgery but have particularly aggressive disease. However, it is not clear how to identify which localized disease patients should receive hormone therapy, and the historical protocol. Read More
Healing and Grace
In many ways, Russell Clayton’s story sounds like an ideal scenario from a prostate cancer playbook: In September 2015, Clayton, a doctor himself – he is an Ob/Gyn in Los Angeles – went for his yearly checkup. He requested a PSA blood test. “My physician wasn’t going to order the. Read More
USPSTF Prostate Cancer FAQs
When health policy makers are making decisions about PSA-based screening, first and foremost, they should bear in mind that the balance of harms and benefits cannot be determined given the current state of science and flawed methodology of the PLCO study. PCF thus calls for a step back from a. Read More
Survivor’s Son: “No reaction is as strong and fierce as when it’s your own family member”
Prostate Cancer Family Member Checklist: Reach Out Learn More Get Involved Ask Ian McLeod how his dad is doing, and he’s happy to tell you: “He’s doing phenomenal. He had a wonderful surgeon, his surgery went without any complications, he healed up nicely and he was out of the hospital. Read More
Treating the Gene
In a matter of weeks, Mark Meerschaert went from being an athlete to someone who could barely walk; metastatic prostate cancer had come from nowhere and spread like wildfire throughout his body. A highly respected mathematics professor and researcher – the kind who fills up the blackboard in his classroom. Read More
Active Surveillance Information
We have emailed you with a list of questions to ask your doctor about Active Surveillance. Read More